Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 23, 2017 Filed Jan 26, 2017 01:49 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 9,637 | $79.99 | $770,907.96 |
DisclosureSEC source: 0001093557-17-000020 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,409 F1 · shares: On December 06, 2016 Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $79.39 to $80.37. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 23, 2017 Filed Jan 26, 2017 01:49 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
Exercise / conversionCommon Stock | 9,637 | $7.79 | $75,072.23 |
DisclosureSEC source: 0001093557-17-000020 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 23:37 UTC |
ROPER JESSSVP, CFO
|
SaleCommon Stock | 3,012 | $85.01 | $256,050.72 |
DisclosureSEC source: 0001093557-17-000017 · edgardoc.xml · nonDerivative · entry 1 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,785 F1 · shares: On November 04, 2016, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from 84.39 to 85.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the LJR Family Trust U/T/A DTD 08/08/2013, with respect to which the reporting person is a trustee. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 01:33 UTC |
SAYER KEVIN RDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $85.94 Strike: $8.79 | $859,362.00 |
DisclosureSEC source: 0001093557-17-000015 · edgardoc.xml · derivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,649 Underlying: Common Stock · 10,000 shares Expires 2017-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 01:33 UTC |
SAYER KEVIN RDirector · President & CEO
|
SaleCommon Stock | 10,000 | $85.94 | $859,362.00 |
DisclosureSEC source: 0001093557-17-000015 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,391 F1 · shares: On December 12, 2016, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.00 to $86.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 160,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 01:33 UTC |
SAYER KEVIN RDirector · President & CEO
|
Exercise / conversionCommon Stock | 10,000 | $8.79 | $87,900.00 |
DisclosureSEC source: 0001093557-17-000015 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:38 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 15,000 | $79.36 Strike: $8.85 | $1,190,400.00 |
DisclosureSEC source: 0001093557-17-000013 · edgardoc.xml · derivative · entry 3 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,939 Underlying: Common Stock · 15,000 shares Expires 2018-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:38 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 15,000 | $79.36 | $1,190,400.00 |
DisclosureSEC source: 0001093557-17-000013 · edgardoc.xml · nonDerivative · entry 2 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,598 F1 · shares: On December 13, 2016, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:38 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Exercise / conversionCommon Stock | 15,000 | $8.85 | $132,750.00 |
DisclosureSEC source: 0001093557-17-000013 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,173 | $80.00 Strike: $9.80 | $573,840.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 7,173 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 8,927 | $80.00 Strike: $9.80 | $714,160.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,927 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 10,000 | $80.00 Strike: $7.63 | $800,000.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | SaleCommon Stock | 7,173 | $80.00 | $573,840.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionCommon Stock | 7,173 | $9.80 | $70,295.40 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | SaleCommon Stock | 10,000 | $80.00 | $800,000.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionCommon Stock | 10,000 | $7.63 | $76,300.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | SaleCommon Stock | 8,927 | $80.00 | $714,160.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | Exercise / conversionCommon Stock | 8,927 | $9.80 | $87,484.60 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 10, 2017 Filed Jan 13, 2017 00:21 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,200 | $62.86 Strike: $9.80 | $201,152.00 |
DisclosureSEC source: 0001093557-17-000009 · edgardoc.xml · derivative · entry 3 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727 Underlying: Common Stock · 3,200 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2017 Filed Jan 13, 2017 00:21 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
SaleCommon Stock | 3,200 | $62.86 | $201,152.00 |
DisclosureSEC source: 0001093557-17-000009 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,345 F1 · shares: On December 09, 2016, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 10, 2017 Filed Jan 13, 2017 00:21 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
Exercise / conversionCommon Stock | 3,200 | $9.80 | $31,360.00 |
DisclosureSEC source: 0001093557-17-000009 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,000 | $63.02 Strike: $8.85 | $189,045.90 |
DisclosureSEC source: 0001093557-17-000007 · edgardoc.xml · derivative · entry 3 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,939 Underlying: Common Stock · 3,000 shares Expires 2018-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 3,000 | $63.02 | $189,045.90 |
DisclosureSEC source: 0001093557-17-000007 · edgardoc.xml · nonDerivative · entry 2 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,598 F1 · shares: On December 13, 2016, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $62.50 to $63.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Exercise / conversionCommon Stock | 3,000 | $8.85 | $26,550.00 |
DisclosureSEC source: 0001093557-17-000007 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 900 | $63.00 | $56,700.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 13 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 900 shares Expires 2018-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Conversion or exercise price of derivative security is $3.19. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,583 | $62.83 Strike: $7.63 | $162,287.57 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 12 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,583 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 7,000 | $63.02 Strike: $7.79 | $441,162.40 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 11 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 417 | $63.49 Strike: $7.63 | $26,474.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 417 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | SaleCommon Stock | 2,583 | $62.83 | $162,287.57 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $62.49 to $63.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionCommon Stock | 2,583 | $7.63 | $19,708.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 7 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | SaleCommon Stock | 900 | $63.31 | $56,980.62 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $63.17 to $63.37. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionCommon Stock | 900 | $3.19 | $2,871.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | SaleCommon Stock | 417 | $63.49 | $26,474.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $63.37 to $63.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionCommon Stock | 417 | $7.63 | $3,181.71 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | SaleCommon Stock | 7,000 | $63.02 | $441,162.40 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $62.48 to $63.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | Exercise / conversionCommon Stock | 7,000 | $7.79 | $54,530.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC |
GREGG TERRANCE HDirector · Executive Chairman
|
Disposition to issuerCommon Stock | 1,511 | $63.50 | $95,948.50 |
DisclosureSEC source: 0001093557-17-000005 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,266 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 44,157 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 10,157 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| December 23, 2016 Filed Dec 29, 2016 01:12 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,182 | $62.17 | $197,831.30 |
DisclosureSEC source: 0001093557-16-000768 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,097 F1 · shares: On June 15, 2016, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.72 to $62.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:46 UTC |
GREGG TERRANCE HDirector · Executive Chairman
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-16-000764 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,882 F1 · shares: This transaction represents a gift of securities made by the reporting person to a donor-advised fund. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. F2 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:20 UTC |
ROPER JESSSVP, CFO
|
SaleCommon Stock | 2,442 | $64.14 | $156,619.38 |
DisclosureSEC source: 0001093557-16-000762 · edgardoc.xml · nonDerivative · entry 1 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,797 F1 · shares: On November 04, 2016, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $63.68 to $64.89. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the LJR Family Trust U/T/A DTD 08/08/2013, with respect to which the reporting person is a trustee. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:20 UTC |
SAYER KEVIN RDirector · President & CEO
|
GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-16-000761 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,391 F1 · shares: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. F2 · balance_after: Included in this number are 160,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 00:58 UTC |
GREGG TERRANCE HDirector · Executive Chairman
|
Disposition to issuerCommon Stock | 2,167 | $64.46 | $139,684.82 |
DisclosureSEC source: 0001093557-16-000756 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,777 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 49,235 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 15,235 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,925 | $64.81 Strike: $7.79 | $254,371.01 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,925 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,637 | $64.81 Strike: $7.79 | $170,898.43 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 2,637 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,438 | $64.81 Strike: $7.25 | $222,809.56 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,438 shares Expires 2017-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | SaleCommon Stock | 3,925 | $64.81 | $254,371.01 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionCommon Stock | 3,925 | $7.79 | $30,575.75 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | SaleCommon Stock | 3,438 | $64.81 | $222,809.56 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionCommon Stock | 3,438 | $7.25 | $24,925.50 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | SaleCommon Stock | 2,637 | $64.81 | $170,898.43 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.